Posts Tagged ‘BUSH’

Babies Can Be Treated With Adult Stem Cells, Even in the Womb | LifeNews.com

In VICTORIES & SUCCESS STORIES on February 13, 2011 at 9:40 am

This is AWESOME!

They’ve been trying to treat fetuses in the womb with stem cells for awhile now (adult stem cells, NOT embryonic!  embryonic can cause tumors!)  In the past, they tried to use the baby’s own stem cells…with mixed results.

“But despite the fact that the immature immune system of an unborn baby can tolerate donor transplants, with little risk of graft rejection, most previous attempts to transplant blood stem cells into a human fetus have been unsuccessful…”


“When transplants were matched to the mother rather than the fetus, the transplants were accepted!…Transplanting stem cells harvested from the mother makes sense because the mother and her developing fetus are prewired to tolerate each other.”


‘in-the-womb treatments for “everything from neurological disorders to muscular disorders before birth.”’

Two recent stories are exciting about the possibility of treating young children, even in the womb, with adult stem cells. One study shows that cardiac adult stem cells can be isolated from young children with heart problems, even as young as one day old…


In VICTORIES & SUCCESS STORIES on February 12, 2011 at 9:41 am


Most Americans with the biggest risks for heart disease are not doing enough to control these risks, and the fragmented U.S. healthcare system is partly to blame, federal health officials said on Tuesday…

U.S. health system not helping heart disease: CDC


In VICTORIES & SUCCESS STORIES on February 11, 2011 at 9:41 am

Until she was 15, Morse had 20/4,000 vision in one eye and only light perception in the other due to optic nerve hypoplasia, or an underdevelopment of the nerve that transmits vision signals from the eye to the brain. She could make out human figures but not see details, could only read if the paper was within inches of her eye, and could only watch TV standing with her nose pressed to the glass…

After raising $15,000 from community donations, the mother and daughter set out for China on July 4…

She received spinal injections of cord blood stem cells each week for six weeks. After her third treatment, she realized she could read and knew the treatments were working…


Treatment with adult stem cells, due to the amazing transformation from blindness to sight, are some of the most powerful success stories in adult stem cell treatments.

·         Macie Morse from Colorado before stem cells had 20/4000 vision in one eye and in the other eye she only had “light perception,” she could only make out light.  Also, she could only watch TV with her nose pressed against the glass. After treatment she had 20/80 vision in one eye and the other is 20/400+.  She is now driving her family’s van and enjoying her new driving permit. https://repairstemcell.wordpress.com/2009/02/16/stem-cells-optic-nerve-hypoplasia-victory/

·         Jakob Bielski from Canada received stem cell treatment because he couldn’t see at all and had no response to light.  After the Cord Blood Stem Cells Were Implanted he has some vision, can respond to visual information and responds to light.

·         Dakota Clarke’s mother said “It’s been worth every single penny to see the changes in her.”

·         Coby Fend’s mother said ““We are talking about going back — we’d almost be crazy not to, because right now it’s the best thing going in the entire world.”

·         Connor Corkern’s mother said: “He’s doing great. He is doing wonderful. It’s like we’ve got a totally new baby.”

·         Cameron Petersen’s Grandma said: “There was nothing for Cameron before this treatment. Now, his world is limitless.”

·         Lydia Black’s father said: “the treatment is already having a huge effect on her life, and he is glad that she was able to receive stem cell treatment…”

·         Savannah Watring’s mother said: “She said hello to herself in an elevator (after seeing her reflection). It blew everyone away. We weren’t expecting that.”

·         Xavier Carballo’s ophthalmologist, Dr. Jack Guggino of Tampa, said he did a baseline exam on the boy before the trip to China and after his return. Before the treatment Xavier could only detect hand motion at 1 to 2 feet, and after the treatment he could count fingers at 3 to 4 feet.  “As far as Xavier is concerned, there has been definite and measurable improvement, neurologically and ophthalmologically,” Guggino said.

·         Lawrence Brown III looks at the number “10” on a family laptop and tells his mother Georgina Brown what the number is as part of a daily exercise to see if his sight is improving. For most people, it is insignificant.  But for Lawrence, 16, who has been blind since birth, it was an exceptional moment.“They call it a really good placebo effect,” Lawrence said. “Whatever, if it’s a placebo effect, I want some more.” https://repairstemcell.wordpress.com/2009/08/09/stem-cell-therapy-shows-results-el-paso-times/

·         Blind Man Can See Again After Stem Cell Therapy – A man blinded after having ammonia squirted in his eye is now able to see again thanks to adult stem cells taken from his own body.  Russell Turnbull, 38, from England had therapy using stem cells taken from his other eye in a research study in London.

·         A study in the New England Journal of Medicine on 112 patients with corneal damage from chemical burns whom received treatment.  After adult stem cell treatment, a permanent restoration of a transparent, renewing corneal epithelium was attained in 76.6% of eyes. The restored eyes remained stable over time, with up to 10 years of follow-up (mean, 2.91±1.99; median, 1.93).  https://repairstemcell.wordpress.com/2010/06/24/chemically-burned-eyes-repaired-with-stem-cells/

VIDEO: Meet Sam, a visual artist who was confronted with the one thing a man in his profession fears most: Compromised vision. In his case his ability to see clearly was being undermined by age-related macular degeneration (AMD.) His Doctor harvests and uses a patient’s own stem cell-rich bone marrow to help effect healing. Sam discerned improvements in his vision within the first ten days following his treatment and siz weeks later the vision in his left eye had improved while that in his right eye was now normal.

If you or a loved one interested in receiving FREE information on currently available stem cell treatments for OPTIC NERVE HYPOPLASIA, SEPTO-OPTIC DYSPLASIA, MACULAR DEGENERATION and OPTIC CHEMICAL BURNS, please contact me at dsgrano@gmail.com or for other options, go to: CONTACT ME


In VICTORIES & SUCCESS STORIES on February 9, 2011 at 9:40 am



Stem cells may hold secret to multiple spinal injury repair

In VICTORIES & SUCCESS STORIES on February 8, 2011 at 9:40 am

CATCH UP!  They’ve been treating SCI patients successfully with stem cells for years now!

Stem cells may hold secret to multiple spinal injury repair

21 January 2011

Scientists may soon be able to repair multiple aspects of a spinal cord injury in humans, using adult stem cells.

A Case Western Reserve University School of Medicine study involving rats showed that use of multipotent adult progenitor cells (mapc) could prevent neuron retraction, promote new neuron re-growth and reduce inflammation in spinal injury.

Researchers will no doubt be hopeful that the development of such treatment can contribute significantly to reducing the costs of spinal injury treatment, which can range between $500,000 (£312,000) and $3 million (£1.9 million) in the US.

Commenting on the findings, published in the Journal of Neuroscience, university professor Jerry Silver explained: “Using preclinical models of spinal cord injury, we found that MAPC can both dynamically regulate macrophages, which cause inflammatory damage, and stimulate neuron growth simultaneously.

“Our results demonstrate that MAPC convey meaningful therapeutic benefits after spinal cord injury.”

Meanwhile, recent research conducted at Otago University suggests that cell tissue extracted from the nose could be transplanted to the site of spinal cord injury.

Scientists are hopeful the procedure could overcome blocks that prevent nerve cells regenerating following damage.

News by Serious Law. Expert legal assistance for those affected by spinal injury

Posted by Timothy Walters

CATCH UP! This is laughable.

In VICTORIES & SUCCESS STORIES on February 4, 2011 at 4:27 pm

CATCH UP! This is laughable. They want to make drugs for heart disease to do what stem cells have been doing for years! Here’s where they are:

“…within the next decade they may have experimental drugs in development that would give certain… kinds of cells in the heart the ability to regenerate tissue, repair damage and therefore combat heart failure….”
“…his researchers had already had some success in using this protein to “wake up” cells known as epicardial cells in mice with damaged hearts.”

1. Thousands of heart disease patients have been treated successfully around the world at stem cell treatment centers since 2004.
2. Prof Doris Taylor proved heart tissue can regenerate with stem cells in the 1990’s, built rodent and human hearts from scratch and opened a lab in Spain that grows entire hearts from the patient’s own stem cells last year.

Scientists look to stem cells to mend broken hearts

LONDON | Tue Feb 1, 2011 4:14am EST

LONDON (Reuters Life!) – Britain’s leading heart charity launched a 50 million pound ($80 million) research project on Tuesday into the potential of stem cells to regenerate heart tissue and “mend broken hearts”…


In BUSINESS OF STEM CELLS on November 11, 2010 at 2:17 pm

In Greek mythology, Panacea (Greek Πανάκεια, Panakeia) was a goddess of healing. She was the daughter of Asclepius and Epione. Panacea and her five sisters each performed a facet of Apollo‘s art: Panacea was the goddess of cures, Iaso was the goddess of recuperation, Hygieia was the goddess of disease prevention, Aceso was the goddess of recovery, and Aglaea was the goddess of natural beauty. (wiki)

Some very well respect doctors, scientists and politicians are still screaming from the roof tops about the benefits of embryonic stem cells and how treatments derived from their funding will be a huge panacea for the world:

“The therapeutic potential of human embryonic stem cells is remarkable and could well prove to be one of the most significant paradigm-shifting advances in the history of medical science…”

It is a lie at worst and couched narrow-focused misinformation at best and it is typical of what we’ve been hearing from the US media for the past 10 years.  I’ll explain why…

These are only a few of my issues with this article:


They say: ‘federal funding for human embryonic stem cell research “is essential” if scientists are to succeed in turning the cells into usable treatments.’


They say: “The therapeutic potential of human embryonic stem cells is remarkable and could well prove to be one of the most significant paradigm-shifting advances in the history of medical science,”

  • They neglect to mention that ESC form cysts/tumors at the site of injection that can become cancerous + they require immunosuppressive drugs. So, at this point, you would have to cure cancer first to use them safely (a not insignificant hurdle to overcome)…then again, if they did cure cancer, then that WOULD be a significant paradigm shift…but that’s not going to happen any time soon either.


They say: “These cells have the unique potential to differentiate into any human cell type and offer real hope of life-affirming treatments for diabetes, damaged heart tissue, arthritis, Parkinson’s, ALS and spinal cord injuries, to name but a few examples.” [to differentiate into any of the 300+ human cell types is pluripotency]

  • ESC are NOT unique. While they are pluripotent, there are also pluripotent ADULT stem cells…there are even pluripotent ‘induced pluripotent stem cells’ but they have they same problems as embryonic stem cells.  And btw, adult stem cells are already successfully treating ‘diabetes, damaged heart tissue, arthritis, Parkinson’s, ALS and spinal cord injuries, to name but a few examples.’


They say:  “…to help ensure the potential of this research is translated into treatments and cures.”

  • Scientists are going to research ESC + push the envelop of our knowledge + understanding. They will do so amidst controversy + debate, but it will happen. And it may produce wondrous things…BUT…it will not generate life saving treatments, not for a long time and maybe not even in our lifetime.  So, dear scientists and politicians: go ahead and solicit funding, pursue knowledge, bang your drums…just don’t try to sell their funding + research as something they are not.  Stop trying to mislead congress and the public.  Stop calling embryonic stem cells a medical nuclear bomb for TREATMENTS.

That bomb already hit + has positively affected 10’s of thousands of patients around the world. That bomb is ADULT stem cells.

ADULT STEM CELLS produce treatments for 130+ diseases.


Scientists to Congress: Pass the stem cell law … while you still can
Supporters of stem cell research want the law passed while  Democrats still have a majority.Supporters of the stem cell research bill want a vote while Democrats, including House Speaker Nancy Pelosi, still have majorities in both houses of Congress. (Alex Brandon/Associated Press
By Karen Kaplan, Los Angeles Times6:22 p.m. CDT, November 5, 2010 // 

The people who bring you advances in medical research have an urgent message for Congress: Pass the Stem Cell Research Advancement Act … while you still can.

In a letter sent Friday to the leadership of the House of Representatives and the Senate, the deans of American medical schools, chief executives of U.S. hospitals and heads of organizations with names like the American Society for Biochemistry and Molecular Biology and the American Society of Human Genetics said that federal funding for human embryonic stem cell research “is essential” if scientists are to succeed in turning the cells into usable treatments.

“The therapeutic potential of human embryonic stem cells is remarkable and could well prove to be one of the most significant paradigm-shifting advances in the history of medical science,” they wrote. “These cells have the unique potential to differentiate into any human cell type and offer real hope of life-affirming treatments for diabetes, damaged heart tissue, arthritis, Parkinson’s, ALS and spinal cord injuries, to name but a few examples.”

The law would reiterate that no federal money can be used to destroy embryos or create cell lines. One of the pluses of passage is that it would ensure that the controversial research be conducted according to strict ethical rules.

The bill has been passed twice before by bipartisan Congresses, though in both cases it was vetoed by then-President George W. Bush. The imperative to pass it in this congressional session was thought to have diminished after President Obama broadened the scope of federal support for stem cell research though an executive order. Then the surprise decision by a U.S. district judge to halt federal funding of embryonic stem-cell research (which was temporarily reversed) underscored the need for congressional action.

And if that’s going to happen, there’s no time like the present.

The scientists don’t say so explicitly, but they must be thinking that their chances will be worse come January, when majority control of the House shifts to the Republicans. Here’s what they did say:

“We urge you to put this legislation on the floor calendar and pass it when Congress returns in November to help ensure the potential of this research is translated into treatments and cures.”

AP’s Fall-out-of-Chair Headline: ‘Adult Stem Cell Research Far Ahead of Embryonic’ | NewsBusters.org


Fall out of chair???  Only if you have ignored my posts for the past 3 years!  My readers have know this TRUTH for years! -dg

AP’s Fall-out-of-Chair Headline: ‘Adult Stem Cell Research Far Ahead of Embryonic’

By Tom Blumer | August 10, 2010 | 00:47

Tom Blumer’s picture

MuscleStemCellsA week ago, AP Science Writer Malcolm Ritter committed a serious act of journalism by telling readers what is really going on in stem cell science. It ought to be required reading for the Obama administration, which seems to be making a crusade out of human embryonic stem cell research (hESCR) while acting to stifle what appears to be significant progress in adult stem cell research (ASCR).

The amazing title of the AP reporter’s article is “Adult stem cell research far ahead of embryonic.” Given the establishment press’s years-long favoritism towards hESCR going back at least to George W. Bush’s 2001 announcement limiting federal government involvement in that area, it’s enough to make you wonder if Ritter knew that his editors were on vacation or away on other business on August 2.

Here are just some of the exemplary paragraphs from Ritter’s long report:

… For all the emotional debate that began about a decade ago on allowing the use of embryonic stem cells, it’s adult stem cells that are in human testing today. An extensive review of stem cell projects and interviews with two dozen experts reveal a wide range of potential treatments.

… Adult stem cells are being studied in people who suffer from multiple sclerosis, heart attacks and diabetes. Some early results suggest stem cells can help some patients avoid leg amputation. Recently, researchers reported that they restored vision to patients whose eyes were damaged by chemicals.

Apart from these efforts, transplants of adult stem cells have become a standard lifesaving therapy for perhaps hundreds of thousands of people with leukemia, lymphoma and other blood diseases.

… Embryonic cells may indeed be used someday to grow replacement tissue or therapeutic material for diseases like Parkinson’s or diabetes. Just on Friday, a biotech company said it was going ahead with an initial safety study in spinal cord injury patients. Another is planning an initial study in eye disease patients later this year.

But in the near term, embryonic stem cells are more likely to pay off as lab tools, for learning about the roots of disease and screening potential drugs.

Some of the new approaches, like the long-proven treatments, are based on the idea that stem cells can turn into other cells. Einhorn said the ankle-repair technique, for example, apparently works because of cells that turn into bone and blood vessels. But for other uses, scientists say they’re harnessing the apparent abilities of adult stem cells to stimulate tissue repair, or to suppress the immune system.

“That gives adult stem cells really a very interesting and potent quality that embryonic stem cells don’t have,” says Rocky Tuan of the University of Pittsburgh.

Though he alludes to the concept in the bolded sentence above, one word missing from Ritter’s report is “potency,” which in stem cell science refers to a cell’s ability to create unrelated types of cells. The Mayo Clinic describes the status of adult stem cells thusly:

… it was thought that stem cells residing in the bone marrow could give rise only to blood cells. However, emerging evidence suggests that adult stem cells may be more versatile than previously thought and able to create unrelated types of cells after all. For instance, bone marrow stem cells may be able to create muscle cells. This research has led to early-stage clinical trials to test usefulness and safety in people.

Mayo also notes that “Researchers have reported being able to transform regular adult cells into stem cells in laboratory studies. By altering the genes in the adult cells, researchers were able to reprogram the cells to act similarly to embryonic stem cells.”

There was a time when “pluripotency,” the ability of a stem cell to give rise to any kind of human cell, was thought to be the sole province of hESCR. That may still conceivably be true, but if enough adult cells of different types can be coaxed into creating other types of cells, they may be able to cover the gamut of human tissue even if none are ever induced into true pluripotency. Besides, some scientists are saying that true pluripotency from adult stem cells is not that far away.

So remind me, if hESCR has such limited use, why did President Obama make such a big deal of reversing President Bush’s Executive Order, thereby allowing federal funds to go into ESCR, while proclaiming that “ensuring that scientific data is never distorted or concealed to serve a political agenda, and that we make scientific decisions based on facts, not ideology”? Perhaps he can explain to Malcolm Ritter how he knows that adult stem cells are Republican, and embryonic ones are Democratic.

Graphic found at the Stem Cell Blog.

via AP’s Fall-out-of-Chair Headline: ‘Adult Stem Cell Research Far Ahead of Embryonic’ | NewsBusters.org.


In VICTORIES & SUCCESS STORIES on May 24, 2010 at 7:56 pm

Another great article that proves the benefits of adult stem cells and the limitations of embryonic stem cell research for treatments.  It goes pretty heavily into the politico-religious issues which I tend to avoid…preferring to focus on the incontrovertible scientific data…but what’s even more amazing is that this was written, unbelievably, in 2005!! I wonder why the US press never picked it up? (sarcasm) -dg

Adult Stem-Cell Treatments: A Better Way 12/1/2005
By Stephanie Porowski and Emma Elliott

Adult stem-cell research may lead one day to cures for terminal and debilitating diseases

“I hope we will always be guided by both intellect and heart,
by both our capabilities and our conscience.”
-President George W. Bush

Few areas of scientific study hold as much potential as adult stem-cell research. This research is already generating medical breakthroughs and treatments for debilitating diseases and disabilities, such as spinal cord injuries, sickle cell anemia and Parkinson’s. Indeed, scientists laud stem-cell treatments as the “miracle cure” of the 21st century. Unlike so many areas of biotechnology, adult stem cells do not spark a heated debate between scientists and ethicists. However, while adult stem-cell research has no moral problems, embryonic stem-cell research (ESCR) ignores the sanctity of human life in the name of scientific “advancement.”

This issue came to the forefront early in President George W. Bush’s first term. In a 2001 address, he remarked that ESCR “lies at a difficult moral intersection, juxtaposing the need to protect life in all its phases with the prospect of saving and improving life in all its stages.”2 Too many scientists and politicians have become focused on making breakthroughs while ignoring their responsibility to protect life. Many ignore the bright prospect of adult stem-cell treatments only to celebrate the still-dim possibility of using embryonic stem cells for miracle cures. Yet, while adult stem-cell treatments often lack media hype and celebrity spokesmen, they consistently prove themselves in study after study. Adult stem cells are poised to improve the lives of millions.


Stem cells are unspecialized cells that continually renew themselves through cell division.3 Unlike other cells, stem cells begin as “blanks” without a dedicated task, but with an ability to become specialized. Scientists hope to use this capability to replace cells damaged by a broad spectrum of diseases.4

Stem cells come in two types: embryonic and adult. Embryonic stem cells have not yet received an “assignment.”5 For this reason, they can develop into a number of different human-cell types.6 Researchers obtain embryonic stem cells from embryos created in fertility clinics and donated to medical research, but many scientists hope to use cloning to mass-produce embryos for this research.

Unlike embryonic cells, adult stem cells can be taken from a variety of sources, including the placenta, umbilical-cord blood, skin, bone marrow, hair and body fat, with no destruction of human life at any stage.7 Adult stem cells normally develop into their tissue of origin, but increasing evidence shows that adult stem cells have the ability to develop into other cell types,8 making these cells a viable alternative to embryonic stem cells.


The alternative of adult stem cells is greatly needed in a scientific community willing to go to nearly any length for medical advancement. The use of the human embryo as a source of stem cells holds terrible ramifications, because the process of removing stem cells destroys the embryo. While scientists try to justify their research with the notion that embryos are not yet human life, many ethicists dismiss this idea for what it clearly is-a lie, a feeble attempt to rationalize their experiments.

According to C. Ward Kischer, a human embryologist, “Virtually every human embryologist and every major textbook of Human Embryology states that fertilization marks the beginning of the life of the new individual human being.”9 [Emphasis in the original.] Professor Hymie Gordon, chairman of the Mayo Clinic, says that, “By all the criteria of modern molecular biology, life is present from the moment of conception.”10 Professor Micheline Matthews-Roth, Harvard University Medical School, states, “It is scientifically correct to say that an individual human life begins at conception.”11 Carrie Gordon Earll, Focus on the Family policy expert, writes:

Biologically, human life begins at conception … when sperm and egg unite. This new embryonic life is 100 percent human, complete with 46 human chromosomes and his or her own genetic code. As the embryo grows, he begins the journey through all of life’s stages: embryo, fetus, infant, toddler, adolescent and adult. To classify any one of these stages as not human discriminates based on age, appearance or location.12

President Bush agrees. He recalls an ethicist’s warning, saying, “Make no mistake, he told me, that cluster of cells is the same way you and I, and all the rest of us, started our lives. One goes with a heavy heart if we use these, he said, because we are dealing with the seeds of the next generation.”13

Many remain undecided about the status of the embryo. Hilde Lindemann Nelson, Ph.D., associate professor of philosophy at Michigan State University, says, “I don’t think there is an easy answer to what we do with these embryos because we don’t yet have any common standing on what kind of moral status they have.”14 Former President Ronald Reagan once stated, “If there’s doubt about it, and if there’s mystery, then shouldn’t we be extraordinarily careful?”15 The smallest possibility of destroying a human life should rule out this research. Science should never advance by sacrificing the very lives it should be trying to save.

Author of Culture of Death: The Assault on Medical Ethics in America, Wesley J. Smith, asks, “Once embryos can be exploited for their stem cells to promote human welfare, what is to stop scientists from manipulating embryos to control and direct human evolution-equally for the purpose of improving the human future?” He notes that many of those who signed a letter to President Bush urging an end to the ban on federal funding for human embryo research were scientists and bioethicists favoring eugenics,16 a movement that ignores the sanctity of human life and undermines God’s role in His creation.

C.S. Lewis emphasized these dangers when he wrote, “If any age really attains, by eugenics and scientific education, the power to make its descendants what it pleases, all men who live after are the patients of that power,” slaves to the “dead hand of the great planners and conditioners.”17


Frighteningly, the 21st century appears to be that age, and scientists may enter this era through the backing of a society that allows them to devalue human life at its earliest and most vulnerable stage.

Not only does the use of embryonic stem cells imperil the sanctity of human life; this “medical miracle” has little scientific validity. These stem cells have not shown any therapeutic benefits to patients. Even leading proponents of ESCR, such as the American Association for the Advancement of Science, admit, “[T]he human embryonic stem cells … that made headlines in November 1998 because they can, in theory, develop into any cell type have so far produced relatively modest results.”18

In fact, in some cases, embryonic stem cells have produced horrific results. Neurology reported one such instance where a patient suffering from Parkinson’s disease died after fetal cells were transplanted into his brain. His autopsy revealed that his death had been caused by growth of bone, skin and hair in the brain, probably due to the “transformation of undifferentiated stem cells into non-neural tissues.”19 Transplant rejection continues to be a major problem.20 According to many reports, in one out of every five cases in animal testing embryonic stem cells trigger tumors at the point of injection.21

Patients who would be treated with these cells would risk serious side effects, such as unstable gene expression (abnormal production of proteins from genes) and inability to stimulate the cells to grow certain types of tissue.22 John B. Shea, M.D., writes, “Even if a specific tissue is successfully produced from embryonic stem cells … therapeutic use of this tissue may cause abnormalities in the person receiving the tissue graft.”23

Moreover, increasing evidence shows that embryonic stem cells are difficult to control and preserve. Dr. Peter Andrews of the University of Sheffield, England, says, “Simply keeping human embryonic stem cells alive can be a challenge.” Doug Melton, Harvard University researcher, adds, “In my view [human embryonic stem cells] would degrade with time.”24 Bioethicist Glenn McGee told Technology Review that “the emerging truth in the lab is that pluripotent stem cells [embryonic stem cells able to develop into all cell types] are hard to reign in. The potential that they could explode into a cancerous mass after a stem-cell transplant might prove to be the Pandora’s Box of stem-cell research.”25


While ESCR consistently turns up dead ends and sometimes-deadly results, adult stem cells continue to amaze researchers with their powers. In fact, the only real medical advances from stem cells have come with adult stem-cell treatments. Hudson Institute Senior Fellow Michael Fumento asserts the advantage of adult stem cells. “Embryonic stem cell research is so far behind it’s like a joke,” he says. “We’re getting everything we need out of nonembryonic stem cells, and what we’re getting is incredible.”26

Recent scientific developments prove this statement true. A few include:

  • Researchers at Australia’s Griffith University discovered that olfactory stem cells can be turned into almost any kind of cell.27
  • Researchers at the University of South Florida Center for Aging and Brain Repair injected human-bone-marrow stem cells into rats that had suffered severe strokes. The infusion of healthy stem cells quickly brought the rats back to such a level of normal activity that it was almost as if they had not suffered the strokes. The rats displayed no motor asymmetry – a common result of strokes.28
  • Researchers at Enzo Biochem Inc. have high hopes of developing a cure for HIV using adult stem cells. They inserted anti-HIV genes into human stem cells, which then developed into a type of white blood cell that blocked HIV growth.29
  • Scientists at Massachusetts General Hospital have found that adult-islet stem cells can mature into pancreatic beta cells, the insulin-secreting cells that diabetes patients need.30
  • Researchers at the University of Oslo are developing a treatment to heal spinal cord injuries using bone-marrow stem cells.31
  • A research team at the University of Central Florida believes a person’s own stem cells may hold the key to curing Alzheimer’s. The team has been injecting rats with bone marrow or blood stem cells, which then proceed to replace the brain cells that are usually destroyed by Alzheimer’s.32
  • The National Institute for Neurological Disorders and Strokes reports that a patient’s own bone-marrow can now be used to create nerve cells that could repair brain damage.33
  • Johns Hopkins researchers have found that a mouse’s own bone-marrow stem cells can develop into the specialized cells lining its intestines, lungs and skin.34
  • Doctors at the Center for Aging and Brain Repair at the University of South Florida have found stem cells in tissue taken from the hearts of newborn babies undergoing surgery to correct congenital heart defects. It may be possible to use these stem cells to treat adults.35
  • Researchers in Milan successfully treated mice with a disease similar to multiple sclerosis (MS) by injecting them with neural stem cells. The injections promoted tissue repair and clinical recovery.36
  • A study published in The Proceedings of the National Academy of Sciences shows that nerve cells can be grown from hair-follicle stem cells.37

More importantly, many of these studies have moved into human clinical trials and have yielded tremendous results in fighting many diseases, including:

    Severe Combined Immunodeficiency (SCID)

  • According to the National Center for Biotechnology Information estimates that new therapies involving the transplanting of bone marrow and other types of adult stem cells save up to 80 percent of SCID patients.38
  • Diabetes

  • In Japan a diabetic woman received part of her mother’s pancreas. The insulin-producing pancreatic stem cells cured her diabetes. This procedure has been successful, but it always required pancreas cells from at least three cadavers. This latest case required only about half the number of cells.39
  • Heart Disease

  • Osiris Therapeutics, a firm developing therapies that use adult stem cells, is testing the possibility of injecting heart-attack patients with stem cells that can migrate into the heart and replace damaged cells.40
  • Multiple studies around the world have shown that adult stem cells improved cardiac functioning for patients. Patients with congestive heart failure saw significant improvement when bone-marrow stem cells were injected into their cardiac tissue.41 One patient who had been bedridden with heart failure was walking three miles a day within months.42
  • Sickle Cell Anemia

  • Doctors at the University of Pittsburgh cured 15-year-old Keone Penn of sickle cell anemia through intensive chemotherapy and injection of stem cells from umbilical-cord blood.43
  • Acute Myeloid Leukemia

  • Treating child leukemia patients with umbilical-cord-blood stem cells has proven extremely effective. Adult Leukemia patients require a much larger quantity of stem cells, making it difficult to treat them, but researchers at the University of Minnesota are developing a therapy which combines stem cells from the blood of two umbilical cords.44
  • Multiple Sclerosis (MS)

  • Several hundred patients worldwide have reported improved conditions after receiving adult stem-cell transplants to treat MS.45
  • Parkinson’s disease

  • An Israeli company is testing a way to treat Parkinson’s using a patient’s bone-marrow stem cells. The cells produce a chemical that restores a patient’s motor movement.46
  • Dennis Turner, who had suffered severe Parkinson’s for many years, was injected with modified stem cells extracted from his brain. For the next five years his Parkinson’s symptoms virtually disappeared and allowed him to live a normal life.47
  • Researchers at the University of South Florida have reported that their attempts to use fetal cell grafts to combat Parkinson’s were completely ineffective.48
  • Crohn’s Disease

  • After adult stem-cell treatment, several patients with severe Crohn’s disease at Chicago’s Northwestern Hospital have shown remarkable progress. The patients had failed to respond to standard treatments.49
  • Krabbe’s Disease

  • Umbilical cord-blood transplants significantly increased the survival rates of newborns afflicted with this rare and usually fatal disease.50

These are just some of the documented examples showing the promise of adult stem cells. Adult stem-cell treatments have successfully fought Tay-Sachs disease, sickle cell anemia, thalassemia major, non-Hodgkin’s lymphoma,51 blindness,52 spinal cord injury53 and renal cell carcinoma. These treatments have also been used to fight many forms of cancer, including ovarian,54 testicular55 and breast.56

Amazing discoveries continue to show that adult stem cells carry all the proposed benefits of embryonic stem cells without the risks. Present in everyone, these cells are noncontroversial and easier to obtain. Furthermore, researchers have found adult stem cells, known as “multipotent adult progenitor cells” (MAPC’s), which, like embryonic stem cells, have the capability to convert into any cell type. They have also found another cell type, the “mesenchymal stem cell” (MSC), capable of making only bone, cartilage, fat and muscle tissues, but with the remarkable ability to cause little or no immune reaction when transplanted.57 Importantly, this cell seems to go only to damaged areas.58

These two findings have incredible implications. But even more astounding is the suggestion that the cells can do something ESCR cannot do?be transplanted without fear of rejection. According to Ross Tubo of the biotech company Genzyme, “Put the properties of the two kinds of cells together and all of a sudden you have a noncontroversial, highly versatile source of adult stem cells that can, in theory, be transplanted to anyone.”59 Everyday, new and ethical discoveries transform today’s science into the cures of tomorrow.


Many scientists and politicians know the facts about adult stem cells. They have seen the research about the mounting failures of embryonic stem cells. So why do so many continue to ignore adult stem-cell treatments while aggressively promoting ESCR? The deeply troubling answer involves the power of the media, the advancement of the abortion and eugenics agenda, and financial profit.

Scientists and politicians, like much of society, are slaves to the media, and a few key celebrities have used the media to promote federal funding of ESCR. Michael J. Fox, who suffers from Parkinson’s, Dana Reeve, widow of paralyzed actor Christopher Reeve, and Mary Tyler Moore, stricken with diabetes, have joined the debate, appealing to emotions in their quest to find a cure for these diseases.

These emotional celebrity appeals advance an abortion agenda. In response to the pro-life outcry about the destruction of human life involved in ESCR, abortion supporters have jumped aboard the embryo-research bandwagon. As Wesley J. Smith writes:

The embryo cell debate offers abortion advocates a “two-fer”: It furthers their primary political goal of isolating and marginalizing pro-lifers, and it enables them to seize the PR high ground by “compassionately” pressing for research that offers hope against debilitating diseases.60

Thus they refuse to acknowledge the tremendous potential of adult stem-cell research, fearing the political consequences. When people learn of this pro-life, superior alternative they understand there is no need to pursue an unethical and inferior choice, one that has been promoted as patients’ only hope.

Supporters of eugenics have always tied themselves closely with the abortion movement. On the issue of ESCR, they take an identical stance, with dangerous consequences. The exploitation of embryos to promote advances in science for the “greater good” could conceivably take the final step into the world of eugenics. Once again scientists would promote the “greater good,” but this time scientific advancement would take the form of genetic screening and cloning to weed out the “inferior” in hopes of improving society eugenically.61

Despite all their efforts on behalf of society, these scientists seem to care little about the individuals who comprise society. Charles Krauthammer describes their real purpose in The Weekly Standard. He writes of embryo research: “It is a clear deception perpetrated by cynical scientists and ignorant politicians. Its purpose is clear: to exploit the desperation of the sick to garner political support for ethically problematic biotechnology.”62

Another very real factor in the propagation-of-the-embryo lie is financial profit. Scientists engaged in the stem-cell debate are often university and research leaders. However, they also often serve as board members or shareholders in biotechnology companies that would thrive with government funding of ESCR. Several prominent scientists serve as faculty at prestigious universities and research institutes but also maintain close ties with biotech companies involved in ESCR. They include:

  • Douglas Melton, Harvard professor and board member of Curis Inc.;
  • Irving Weissman, Stanford scientist and founder of two biotech companies;
  • Ronald McKay, National Institute of Health (NIH) scientist and a founder and shareholder of NeuralSTEM Biopharmaceuticals.

These men all have a financial interest in the outcome of the stem-cell debate. The media have quoted these “experts” hundreds of times regarding their support of ESCR, but rarely mention their financial stake in the debate.63

In addition, some politicians do not have the courage or character to consider the truth. Worse, they feed the lies. Typical of this deception, Sen. Tom Harkin (D-Iowa) speaks of “so much promise” for incredible medical advancement using ESCR.64 “So much promise?” Scientists have not come close to finding safe, effective cures with this research.

Sen. Arlen Specter (R-Pennsylvania) states with similar intent, “It is scandalous, absolutely scandalous, that there are so many people with Alzheimer’s and Parkinson’s and heart disease and cancer. … [N]ot to have the availability of the best in medical care is simply atrocious.”65

America cannot justify the cost of ESCR to our humanity. Moreover, the advances with adult stem cells prove America does not face an impossible ethical dilemma.


And so the lie continues, influencing the debate on embryonic research policy. Although the United States government banned federal funding for research involving the harming or destruction of embryos in 1996, the Clinton administration quickly proposed a way to bypass the law. Under guidelines endorsed by the National Institutes of Health, the government would ignore the research as long as the embryos were killed by a nongovernment-funded source in a “government-approved manner.” The guidelines were largely the work of Marcy Wilder, who had served as legal director to NARAL pro-Choice America immediately prior to joining the Department of Health and Human Services.66

Notably, several politicians have taken a stand against ESCR. Sen. Sam Brownback (R-Kansas), for example, firmly opposes ESCR and advocates adult stem-cell research.67 Rep. Chris Smith (R-New Jersey) also condemns ESCR and pushes for ethical alternatives, including bolstering the nation’s supply of cord-blood stem cells.68

Likewise, the current administration under President Bush refuses to waver from his policy that federal funds should not be used as an incentive to kill embryos. Even as a candidate, he stated, “Taxpayer funds should not underwrite research that involves the destruction of live human embryos.”69 In reviewing the issue, the administration concluded that the type of funding proposed by the Clinton administration violated the law.

In August of 2001, President Bush announced his decision on this defining moral issue. He stated that the government will not support the destruction of embryos with federal funds,70 but that he would permit funding of research on already existing stem-cell lines.71 Adult stem-cell research will also continue, with the National Institutes of Health giving $203.3 million to the research in 2005.72 Furthermore, President Bush established the President’s Council on Bioethics, initially chaired by Dr. Leon Kass, a University of Chicago bioethicist. TIME magazine quotes the doctor, who wrote, “By pouring our resources into adult-stem cell research … we can avoid the morally and legally vexing issues in embryo research.”73

Since President Bush’s decision, Congress has made several attempts to bypass him by enacting legislation to grant federal funding to stem-cell research. To date no such legislation has passed both houses. If it does, the President has vowed to veto it.

During World War II the Germans conducted inhumane experiments on concentration camp victims. Their findings could have been used for medical advancement. But ethical scientists around the world refused to use the information because of how it was obtained.74 They refused to legitimize murder.

Like these scientists, Americans should not condone research that denies the sanctity of human life, especially when an ethical, more scientifically viable alternative exists. Adult stem-cell research must go on, with full support from the American people. The embryonic stem-cell lie must be confronted with the hope of adult stem-cell treatments-the demonstrated “miracle cure.”

NOVEMBER 17, 2005

End Notes

  1. “Remarks by the President on Stem Cell Research,” 9 August 2001, from the White House Web site, as found at http://www.whitehouse.gov/news/releases/2001/08/20010809-2.html.
  2. Ibid.
  3. “Stem Cells: A Primer,” from the National Institutes of Health Web site, as found at http://www.nih.gov/news/stmcell/primer.htm
  4. “Baby Teeth Offer Another Effective Source of Adult Stem Cells,” United Press International, from the Christian Life Resources Web site, 22 April 2003, as found at http://www.christianliferesources.com/cgi-bin/prDisplay.pl?displayContent&releaseID=3788&categoryID=56.
  5. Carrie Gordon Earll, “Stem Cell Research: Truth vs. Hype,” from Focus on the Family, as found at http://www/family.org/fofmag/sl/a0024064.cfm.
  6. Dianne N. Irving, “The Stem Cell Decision in the Labs, Beware of Flawed Ethics and False Science,” from Newsday, 15 July 2001, as found at http://www.newsday.com/coverage/current/books/Sunday/nd9784.htm.
  7. Op cit.
  8. “Stem Cells: A Primer.”
  9. C. Ward Kischer, “When Does Human Life Begin? The Final Answer,” from the Life Issues Web site, as found at http://www.lifeissues.net/writers/kisc/kisc_04whenlifebegins1.html.
  10. Randy Alcorn, “Scientists Attest to Life Beginning at Conception,” from Eternal Perspective Ministries Web site, as found at http://www.epm.org/articles/life_conception.html.
  11. Ibid.
  12. Earll.
  13. “Remarks by the President on Stem Cell Research.”
  14. Vida Foubister, “Extra Embryos: What is Their Future?” from the American Medical News Web site, 13 November 2001, as found at http://www.ama-assn.org/sci-pubs/amnews/pick_00/prsa1113.htm.
  15. Joel Belz, “If There is Mystery,” WORLD, 18 August 2001, 5.
  16. Wesley J. Smith, “The Politics of Stem Cells: The Good News You Never Hear,” from the National Right to Life Web site, 21 March 2001, as found at http://www.nrlc.org/news/2001/NRL04/wes.htm.
  17. “The Sanctity of Life in a Brave New World: A Manifesto on Biotechnology and Human Dignity,” from the Council for Biotechnology Policy Web site, as found at http://www.biotechpolicy.org/BiotechPolicy/ChannelRoot/Features/The+Sanctity+of+Life+in+a+Brave+New+World.htm.
  18. Richard M. Doerflinger, “Human Embryo Research: Where We’ve Been, Where We Should Go,” from the National Right to Life Web site, 9 February 2001, as found at http://www.nrlc.org/news/2001/NRLO2/doer/htm/.
  19. Smith.
  20. Kelly Hollowell, “Federal Stem Cell Research: What Taxpayers Should Know,” Heritage Foundation panel discussion, 24 June 2005, as found at http://www.heritage.org/Research/HealthCare/wm749.cfm.
  21. “Adult Stem Cell Breakthrough Ignored,” from Newsmax Web site, 30 May 2005, as found at http://www.newsmax.com/archives/ic/2005/5/30/84930.shtml.
  22. Linda K. Bevington, “Stem-Cell Research and ‘Therapeutic’ Cloning: A Christian Analysis,” from the Center of Bioethics and Human Dignity Web site, as found at http://www.cbhd.org/resources/cloning/scr_overview.htm.
  23. John B. Shea, M.D., “The Current Status of Adult and Embryonic Stem-Cell Research,” prepared for the Campaign Life Coalition, 19 April 2002.
  24. Ibid.
  25. Smith.
  26. Karla Dial, “Bush Makes Pro-Life Choice on Stem Cells,” from the Citizen Web site, as found at http://www.family.org/cforum/citizenmag/webonly/a0017192.html.
  27. “Adult Stem-Cell Breakthrough Ignored.”
  28. Marisa Emerson, “Stem-like cells form Peripheral Blood Restore Function in Rats with Severe Stroke,” from Eurekalert Web site, 6 July 2003, as found at http://www.eurekalert.org/pub_releases/2003-07/uosf-scf063003.php.
  29. Ibid.
  30. “Hormone Prompts Adult Stem Cells to Differentiate into Islet Cells,” from Science Daily Web site, July 17, 2002, as found at http://www.sciencedaily.com/releases/2002/07/020777717075426.htm.
  31. E. J. Mundell, “Adult Stem Cells Can Produce Brain Cells,” from WRKN-TV Web site, 21 March 2005, as found at http://www.wkrn.com/Global/story.asp?S=3107692.
  32. Chad Binette, “Research May Hold Promise for Treating Alzheimer’s,” from News and Information: the Official Source of Information for the University of Central Florida, 10 February 2005, as found at http://news.ucf.edu/UCFnews/index?page=article&id=00240041998c09010172bc803800783d&mode=news.
  33. Ibid.
  34. “Bone Marrow Stem Cells Can Become Almost Anything,” Culture of Life Foundation, from the Daily University Science News, 4 May 2001, as found at http://www.christianity.com/partner/Article_Display_Page/0,PTID4211/CHID403309, 00.html.
  35. Amanda Gardner, “Cardiac Stem Cells Found in Newborns,” from Associated Press Web site, 9 February 2005, as found at http://health.myway.com/art/id/523894.html.
  36. “Researchers Report Successful Transplants of Cells to Repair Neural Tissue Damage in Mice with MS-Like Disease,” a Research/Clinical Update from the National Multiple Sclerosis Web site, 18 April 2003.
  37. “Hair is a Good Source of Stem Cells,” from BBC News, 28 March 2005, as found at http://news.bbc.co.uk/1/hi/health/4378941.stm.
  38. “Severe Combined Immunodeficiency,” from the National Center for Biotechnology Web site, as found at http://www.ncbi.nlm.nih.gov/disease/SCImm.html.
  39. Anita Manning, “Pancreatic Cell Transplant Could Lead to Diabetes Cure,” from USA Today, 18 April 2005, as found at http://www.usatoday.com/news/health/2005-04-18-transplant-diabetes_x.htm.
  40. Michael Rosenwald, “Researchers Turn to Adult Stem Cells,” from The Washington Post, 20 August 2004, E01.
  41. Anita Srikameswaran, “Stem Cells to be Tested in Repairing Heart Muscle,” from the Pittsburgh Post Gazette, 13 May 2005, as found at http://www.post-gazette.com/pg/05133/503928.stm.
  42. Paul Harsim, “Las Vegan in Stem Cell Study,” from the Review Journal, 22 August 2004, as found at http://www.reviewjournal.com/lvrj_home/2004/Aug-22-Sun-2004/news/24586059.html.
  43. Earll, “Adult Stem Cells: It’s Not Pie in the Sky.”
  44. “Cord Blood Transplantation Now a Viable Option for Adult Leukemia Patients,” from Medical News Today, 20 January 2005, as found at http://www.medicalnewstoday.com/medicalnews.php?newsid=19066.
  45. Earll, “Adult Stem Cells: It’s Not Pie in the Sky.”
  46. Roberta Neiger, “Israeli Therapy uses Adult Stem Cells to Treat Parkinson’s Disease,” from Israel 21c, 27 March 2005, as found at http://www.israel21c.org/bin/en.jsp?enDispWho=Articles^l952&enPage=BlankPage&enDisplay=view&enDispWhat=object&enVersion=0&enZone=Health.
  47. Dennis Turner, “Testimony before the Senate Committee on Commerce, Science and Transportation.” 14 July 2004, as found at http://commerce.senate.gov/hearings/testimony.cfm?id=1268&wit_id=3676.
  48. Roberta Friedman, PhD, “Fetal Cell Grafts not Effective in Reversing Parkinson’s Damage: Presented at SFN,” 13 November 2003, as found at http://www.docguide.com/news/content.nsf/news/8525697700573E1885256DDD0064B02F.
  49. “Crohn’s Disease: Hematopoietic Stem Cell Transplantation is Option for Patients with Severe CD,” from Blood Weekly, 13 November 2003, p. 23.
  50. “Umbilical Cord-Blood Transplants Save Lives of Babies with Rare Genetic Disorder, Krabbe’s Disease,” from Medical News Today, 22 May 2005, as found at http://www.medicalnewstoday.com/printerfriendlynews.php?newsid=24897.,
  51. Kelly Hollowell J.D., Ph.D., “Federal Stem Cell Research: What Taxpayers Should Know,” from Heritage Foundation panel discussion, 24 June 2005, as found at http://www.heritage.org/Research/HealthCare/wm749.cfm.
  52. “I Lived to See My Miracle,” from The Daily Telegraph, 29 April 2005, as found at http://www.telegraph.co.uk/health/main.jhtml?view=DETAILS&grid=P8&targetRule=10&xml=/health/2005/04/29/hstem29.xml.
  53. “Stem Cell Help for Spinal Injury,” from One News, 18 February 2004, as found at http://onenews.nzoom.com/onenews_detail/0,1227,256422-1-7,00.html.
  54. “Experimental Ovarian Cancer Treatment: Stem Cell Transplant is Most Aggressive Therapy,” from The University of Texas MD Anderson Cancer Center Web site, September 2004, as found at http://www.cancerwise.org/september_2004/print.cfm?id=2d59e4ed-f917-40b9-85fda5fddfc1683f&method=DisplayFull.
  55. “Bone Marrow Transplant Patient Information,” from the Fox-Chase Cancer Center, 23 December 2003, as found at http://www.fccc.edu/clinical/bonemarrow.
  56. Carr, Jessica, “Local Cancer Patient to Receive Stem Cell Transplant,” from The Coventry Courier, 4 November 2003, as found at http://www.zwire.com/site/news.cfm?newsid=7682235&BRD=1720&PAG=461&dept_id=74554&rfi=6.
  57. Sylvia Pagan Westphal, “Greater Potential of Adult Stem Cells Revealed,” from New Scientist Online News, 17 May 2003, as found at http://www/newscientist.com/news/news.jsp?id=ns99993723.
  58. Rev. Douglas B. Hunt, “‘Miracle’ Stem Cell Find,” from the Religious Center on Biotechnology, 13 August 2001, as found at http://www.ananova.com/news/story/sm_373677.html.
  59. Op cit.
  60. Smith.
  61. Ibid.
  62. Charles Krauthammer, “The Great Stem Cell Hoax,” from The Weekly Standard, 27 August 2001, 12.
  63. Neil Munro, “Mixing Business with Stem Cells,” from National Journal, 21 July 2001, 2348-2349.
  64. Laurie Kellman, “Harkin: Lift Stem Cell Restrictions,” from Associated Press, 12 July 2005, as found at http://wjla.com/news/stories/0705/242898.html.
  65. Jill Zuckman, “Stem Cell Debate Hits Close to Home in House, Senate,” from the Chicago Tribune, 27 June 2005, as found at http://www.chicagotribune.com/news/nationworld/chi-0506270171jun27,1,2768572.story?coll=chi-newsnationworld-hed.
  66. John J. Miller, “Hard Cell: A powerful Coalition Pushes to Subvert the Ban on Human-Embryo Research.” National Review, 5 April 1999.
  67. From the Sen. Sam Brownback Web site, as found at http://brownback.senate.gov/LIStemCellText.htm.
  68. From the Rep. Chris Smith Web site, as found at http://www.house.gov/apps/lisst/press/nj04_smith/prcordblood.htm.
  69. Doerflinger.
  70. Bill Sammon, “Bush Pledges Not to Expand Stem-Cell Funds,” from The Washington Times, 13 August 2001, p. A1.
  71. William Kristol, “Stemming the Tide,” from The Weekly Standard, 27 August 2001, 11.
  72. “Investing in Embryonic Stem Cell Research,” from the World Health Web site, 26 October, 2005, as found at http://www.worldhealth.net/p/investing-in-embryonic-stem-cell-research-2005-07-19.html.
  73. Michael Orecklin, “Leon Kass: The Ethics Cop,” from TIME, 20 August 2001, 23.
  74. Ibid.

US is #1 in Stem Cell Research! …sort of…

In BUSINESS OF STEM CELLS, CATCH UP! on April 29, 2010 at 7:39 pm

We are #1!

With the release of new lines of embryonic stem cells, the US may reclaim their title as #1!  But #1 in what regard? Consumption of stem cells?  Not quite…

Consumption of embryonic stem cells?  Well, yes…but…

We are really only the leader in “consumption of embryonic stem cells used for research”.  But there is a reason for this.  Many countries have tried to research embryonic stem cells for treatment, for a decade or more, with full governmental and fiduciary support and then…given up.  Embryonic stem cells bring with them transplant rejection issues and grow into tumors and cysts.

We are in fact about 8 years behind most of the developed world in adult stem cell research; the only stem cells that have over half a decade of proven safety and efficacy.  So hooray for us!

What else are we #1 in?

We are the…

  • #1 consumer of the stem cells that have shown the least potential for treatment (embryonic)!
  • #1 consumer of environmentally damaging and war causing oil!
  • #1 consumer of cocaine (shipped from Colombia through Mexico and the Caribbean), Colombian heroin, and Mexican heroin and marijuana!

Here’s an idea, snarky as it may be…
What do you say we load up an SUV with cocaine and heroin, have a slammin party, OD on drugs and die young!  We might as well cause embryonic stem cells won’t produce cures for diseases anytime soon!

Not a bad idea, at least we could go out with a bang…If only we could afford it.

Our country’s bank account is more than $-568,800,000,000 ranking us 188th in the world.  Not to worry, we still have a good chance of dying before needing stem cells.  The WHO ranks our health system at 37th, our life expectancy is 30th in the world, infant mortality is 34th in the world and this is all with our Health Expenditures as a % of GDP being almost the highest in the world (we are ranked #2).   Now that’s money well spent.

And we’ll all probably be shot soon anyway.  We are ranked 78th in intentional homicides (and in this category, #1 is good).

HOORAY FOR THE U.S.A.! What’s not to love? – dg

%d bloggers like this: